Local drug delivery: Impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wall

Catheterization and Cardiovascular Interventions

Volumn 47, Issue 1, 1999, Pages 102-106

  Baumbach, Andreas ^a,c   Herdeg, Christian ^a   Kluge, Michael ^b   Oberhoff, Martin ^a   Lerch, Matthias ^a   Haase, Karl K ^a   Wolter, Garsten ^b   Schröder, Stephen ^a   Karsch, Karl R ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Knoll AG   (Germany)

^c Medizinische Klinik III   (Germany)

Author keywords

Local drug delivery; Paclitaxel; PTCA; Radiolabelled; Reviparin

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; PACLITAXEL; REVIPARIN; TAXANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY WALL; ARTICLE; BALLOON CATHETER; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; STENT; SWINE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANIMALS; ARTERIES; DRUG DELIVERY SYSTEMS; HEPARIN, LOW-MOLECULAR-WEIGHT; PACLITAXEL; PHARMACOKINETICS; PRESSURE; SOLUBILITY; STENTS; SWINE; TRITIUM;

EID: 0033028533     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-726X(199905)47:1<102::AID-CCD22>3.0.CO;2-G     Document Type: Article

References (24)

1. Riessen R, Isner JM. Prospects fo site-specific delivery of pharmacologic and molecular therapies. J Am Coll Cardiol 1994;23:1234-1244.
2. Wolinsky H, Thung SN. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol 1990;15:475-481.
3. Wolinsky H, Lin C-S. Use of the perforated balloon catheter to infuse marker substances into diseased coronary artery walls after experimental postmortem angioplasty. J Am Coll Cardiol 1991;17: 174B-178B.
4. Moura A, Lam JY, Hebert D, Kermode JR, Grant GW, Robitaille D, Klein EJ, Yock PG, Simpson JB, Kaplan AV. Intramural delivery of agent via a novel drug-delivery sleeve: histological and functional evaluation. Circulation 1995;92:2299-2305.
5. Gonschior P, Pahl C, Huehns TY, Gerheuser F, Erdemci A, Larisch K, Dellian M, Deil S, Goetz AE, Lehr HA, Höfling B. Comparison of local intravascular drug-delivery catheter systems. Am Heart J 1995;130:1174-1181.
6. Gottsauner-Wolf M, Jang Y, Penn MS, Kaplan AV, Ellis SG, Chisolm GM, Topol EJ, Lincoff AM. Quantitative evaluation of local drug delivery using the InfusaSleeve catheter. Cathet Cardiovasc Diagn 1997;42:102-108.
7. Roth D. Untersuchungen zur Etablierung von Kulturen aus Gefässwandzellen des Menschen für pharmakologische Prescreening-Verfahren. Dissertation der Fakultät für Chemie und Pharmazie der Eberhard-Karls-Universität Tübingen, 1990,
8. Axel DI, Göggelmann C, Wild DH, Kövecker G, Brehm BR, Karsch KR. Effect of paclitaxel on human arterial smooth muscle cells in vitro: a new pharmacological approach in the prevention of restenosis? Eur Heart J 1995;16(suppl):383.
9. Hanke H, Oberhoff M, Hanke S, Hassenstein S, Kamenz J, Schmid KM, Betz E, Karsch KR. Inhibition of cellular proliferation after experimental balloon angioplasty by low-molecular-weight heparin. Circulation 1992;85:1548-1556.
10. Oberhoff M, Herdeg C, Baumbach A, Shamet K, Kranzhöfer A, Weingärtner O, Rübsamen K, Kluge M, Karsch KR. Time course of smooth muscle cell proliferation after local drug delivery of low molecular weight heparin using a porous balloon catheter. Cathet Cardiovasc Diagn 1997;41:268-274.
11. Scollot SJ, Cheng L, Pauly RR, Jenkins GM, Monticone RE, Kuzuya M, Froehlich JP, Crow MT, Lakatta EG, Rowinsky EK, Kinsella JL. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest 1995;95:1869-1876.
12. Kaplan AV, Vandormael MG, Hofmann M, Weil HJ, Stoerger H, Krajcar M, Gallant P, Simpson JB, Reifart N. Heparin delivery at the site of angioplasty with a novel drug delivery sleeve. Am J Cardiol 1996;77:307-310.
13. Herdeg C, Oberhoff M, Baumbach A, Haase KK, Horch B, Kranzhöfer A, Karsch KR. Local drug delivery with the porous balloon in the rabbit: assessment of vascular injury for an improvement of application parameters. Cathet Cardiovasc Diagn 1997;41:308-314.
14. Lambert CR, Leone JE, Rowland SM. Local drug delivery catheters: functional comparison of porous and microporous designs. Coronary Artery Dis 1993;4:469-475.
15. Camenzind E, Bakker W, Reijs A, Van Geijlswijk I, Boersma E, Kutryk MJB, Krenning EP, Roelandt J, Serruys PW. Site-specific intracoronary heparin delivery in humans after balloon angioplasty: a radioisotopic assessment of regional pharmacokinetics. Circulation 1997;96:154-165.
16. Camenzind E, Reys A, Ligthart J, Bakker W, Van Geijlswijk I, Fioretti P, Krenning E, Serruys PW. Local intracoronary delivery of heparin and of a somatostatin analogue (Octreotide) following angioplasty in man: evaluation of efficacy of delivery by radioisotopic technique. J Am Coll Cardiol 1995;25:285A.
17. Camenzind E, Schaar M, Bakker W, Boersma E, Foley D, Van der Giessen WJ, De Feyter PJ, Krenning E, Roelandt J, Serruys PW. First experience in human: safety and feasibility of local intracoronary heparin delivery using the channel balloon. Eur Heart J 1997;18:507.
18. Camenzind E, Bakker W, van Harskamp E, Van Geijlswijk I, Boersma E, Van der Giessen WJ, Krenning E, Foley DP. First quantification of intramural heparin delivery in man using the nipple-catheter (Infiltrator) following coronary balloon angioplasty. Circulation 1997;96:I527.
19. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard A, Satler LF, Kent KM, Griffin J, Leon MB. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996;94:1247-1254.
20. Bartorelli AL, DeCesare NB, Kaplan AV, Fabbiocchi F, Montorsi P, Squadroni L, Galli S, Sganzeria P, Loaldi A. Local heparin delivery prior to coronary stent implantation: acute and six-month clinical and angiographic results. Cathet Cardiovasc Diagn 1997; 42:313-320.
21. Deutsch E, Kiescz RS, Martin JL, Buszman P, Rewicki M, Kosmider M, Sewriniak P, Tarazona N, Tindera M: Favorable impact of intramural low molecular weight heparin delivered at the time of coronary stent deployment on late loss in denovo lesions. Circulation 1997;96:I710.
22. Reimers B, Akiyama T, Moussa I, Blengino S, Di Francesco L. Persistent high restenosis after local delivery of long acting steroids prior to coronary stent implantation. Circulation 1997;96: 1710.
23. Nicosia A, Van der Giessen WJ, Airiian SG, von Birgelen C, De Feyter PJ, Serruys PW. Is intravascular ultrasound after coronary stenting a safe procedure? three cases of stent damage attributable to ICUS in a tantalum coil stent. Catheter Cardio Diag 1997;40:265-270.
24. Wilensky RL, March KL, Gradus-Pizlo I, Schauwecker D, Michaels MB, Robinson J, Carlson J, Hathaway DR. Regional and arterial localization of radioactive microparticels after local delivery by unsupported or supported porous balloon catheters. Am Heart J 1995;129:852-859.